“Steplife,” the world’s first app developed to prevent the exacerbation of diabetes with a mission of “zero lower limb amputations.” Previously, foot checks at home were conducted on paper, not benefiting from digitalization. As a result, communication with patients was hindered, leading to delays in identifying abnormalities or problems between consultations. However, by using “Steplife,” the inconvenience of paper-based methods and challenges in information sharing are resolved. It enables real-time monitoring of patients’ foot health, facilitating early detection of issues. Consequently, patient care becomes more effective, reducing the risk of complications. Moreover, functionalities previously unattainable with traditional electronic medical records or dialysis management systems are provided, making diabetes management more efficient and modern. “Steplife” innovates diabetes management, attracting attention as a new tool for achieving effective care.
“Steplife” is characterized by a novel approach supervised by diabetes specialists, including experienced nurses from the field. The team includes foot care specialists who have cared for over 1,000 diabetes patients’ foot health. Notably, these nurses have never allowed a single patient they’ve encountered to undergo limb amputation. This reliability, backed by their experience and knowledge as patient care professionals, is integrated into “Steplife” as a feature.
Limb amputation among diabetes patients is a serious global issue. “Steplife” holds significant potential to save diabetes patients worldwide, not only in Japan.
